Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 9, 2019 Off

Knopp Biosciences to Present Clinical Data for Dexpramipexole at 11th Biennial Symposium of the International Eosinophil Society

By BusinessWire

Dexpramipexole demonstrated significant reduction of eosinophil levels in blood and inflamed tissues PITTSBURGH–(BUSINESS WIRE)–#ALS–Knopp Biosciences LLC, a privately held drug…

Glenmark OKd by USFDA for generic of Ranexa
July 9, 2019 Off

Glenmark OKd by USFDA for generic of Ranexa

By Dino Mustafić

Glenmark Pharmaceuticals got the final approval by the US FDA for its Ranolazine Extended-Release Tablets, generic version of Gilead’s Ranexa.

July 9, 2019 Off

Arcis Biotechnology and Opentrons Sign Distribution Agreement

By BusinessWire

Providing researchers with an automated solution for two-step nucleic acid sample preparation DARESBURY, England–(BUSINESS WIRE)–Arcis Biotechnology (“Arcis”), the nucleic acid…

Dilafor enrolls the first patient to test tafoxiparin in certain pregnant women
July 9, 2019 Off

Dilafor enrolls the first patient to test tafoxiparin in certain pregnant women

By Dino Mustafić

Karolinska Development’s drug developer Dilafor AB, focused on tafoxiparin for obstetric indications, has enrolled the first subject in its Phase 2b study with tafoxiparin in pregnant women planned for labor induction, Karolinska said Tuesday in a press release.

Cellectis Publishes New CAR Design to Control CAR T-Cells in Non-Lethal Way
July 9, 2019 Off

Cellectis Publishes New CAR Design to Control CAR T-Cells in Non-Lethal Way

By BusinessWire

“The SWIFF-CAR system does precisely that, representing a major breakthrough in our ongoing efforts to develop innovative applications to treat a range of diseases, including cancer and autoimmune diseases.”

Dr. Reddy’s Announces the Launch of the Over-the-counter Store Brand Equivalent of Mucinex® D Extended Release Tablets in Two Strengths in the U.S. Market
July 9, 2019 Off

Dr. Reddy’s Announces the Launch of the Over-the-counter Store Brand Equivalent of Mucinex® D Extended Release Tablets in Two Strengths in the U.S. Market

By BusinessWire

Dr. Reddy’s Laboratories today announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets

Agreement With Farmalabor Gives EMMAC Immediate Access to Italy, Europe’s Second-Largest Medical Cannabis Market
July 9, 2019 Off

Agreement With Farmalabor Gives EMMAC Immediate Access to Italy, Europe’s Second-Largest Medical Cannabis Market

By BusinessWire

LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce that it has formed a…

Dabigatran’s safety and efficacy established for management of VTE in children
July 9, 2019 Off

Dabigatran’s safety and efficacy established for management of VTE in children

By BusinessWire

Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.

July 9, 2019 Off

KAM (Key Account Management) Metrics: Measuring Success 2019 – 5 Current Issues & Their Impact – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “KAM Metrics: Measuring Success (2019)” report has been added to ResearchAndMarkets.com’s offering. Key Account Management teams are still…

July 9, 2019 Off

Metavant and Poxel Announce Positive Topline Safety and PK/PD Results of Imeglimin in Patients with Type 2 Diabetes and Chronic Kidney Disease Stages 3b/4

By BusinessWire

Trial met its primary objective with imeglimin observed to have a favorable safety and tolerability profile in patients with type…

Posts pagination

Previous 1 … 3,021 3,022 3,023 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine